Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
05-14 | Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment | MT |
04-30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+6.49% | 13.11B | |
+11.85% | 9.55B | |
+0.25% | 5.61B | |
+8.56% | 5.6B | |
+7.08% | 5.26B | |
+32.18% | 5.22B | |
+24.64% | 4.77B | |
+2.65% | 4.09B | |
+7.62% | 4.05B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- BofA Securities Downgrades Evotec to Neutral From Buy, Price Target is $13